NanoSphere Health Sciences Inc.
NSHSF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $3 | $0 | $0 |
| G&A Expenses | $0 | $29 | $39 | $44 |
| SG&A Expenses | $52 | $29 | $39 | $44 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $4 | $3 | $4 |
| Operating Expenses | $52 | $36 | $42 | $48 |
| Operating Income | -$52 | -$36 | -$42 | -$44 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $42 | $20 | -$55 | $452 |
| Pre-Tax Income | -$9 | -$16 | -$97 | $407 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$9 | -$16 | -$97 | $407 |
| % Margin | – | – | – | – |
| EPS | 0 | -0.002 | -0.009 | 0.04 |
| % Growth | 100% | 84% | -123.7% | – |
| EPS Diluted | 0 | -0.002 | -0.009 | 0.04 |
| Weighted Avg Shares Out | 10,275 | 10,275 | 10,275 | 10,275 |
| Weighted Avg Shares Out Dil | 10,275 | 10,275 | 10,275 | 10,275 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $0 | $1 | $1 |
| Depreciation & Amortization | $0 | $0 | $39 | $29 |
| EBITDA | -$8 | -$16 | -$57 | $408 |
| % Margin | – | – | – | – |